SLS 18RS-141 ORIGINAL
2018 Regular Session
SENATE BILL NO. 27
BY SENATOR MILLS
MEDICAID. Provides relative to the Medicaid Pharmaceutical and Therapeutics
Committee. (8/1/18)
1 AN ACT
2 To amend and reenact R.S. 46:153.3(D)(1) and (2), relative to the Medicaid Pharmaceutical
3 and Therapeutics Committee; to provide for committee composition; to provide for
4 committee diversity; to provide for nominating entities; to provide for filling of
5 vacancies; and to provide for related matters.
6 Be it enacted by the Legislature of Louisiana:
7 Section 1. R.S. 46:153.3(D)(1) and (2) are hereby amended and reenacted to read
8 as follows:
9 ยง153.3. Medical vendor reimbursements; allowable restrictions; peer-based
10 prescribing and dispensing practice patterns; Medicaid
11 Pharmaceutical and Therapeutics Committee
12 * * *
13 D.(1) The Medicaid Pharmaceutical and Therapeutics Committee, hereinafter
14 referred to as "the committee", is hereby created within the Louisiana Department
15 of Health. The committee shall be composed of twenty-one fifteen members
16 appointed by the governor and submitted to the Senate for confirmation. The
17 committee shall be representative of the state's geographic and demographic
Page 1 of 4
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 27
SLS 18RS-141 ORIGINAL
1 composition, including women and minorities. The governor shall ensure that
2 appointments achieve race, gender, and geographic diversity.
3 (2)(a) Each nominating organization shall certify by affidavit that the practice
4 of each nominee involves either the care of or the supervision of the care of no less
5 than one hundred Medicaid recipients. The committee shall be comprised of the
6 following persons:
7 (a)(i) One physician with expertise in the area of pharmacology representing
8 nominated by the Louisiana State University Health Sciences Center.
9 (b)(ii) One physician with expertise in the area of pharmacology representing
10 nominated by Tulane University School of Medicine.
11 (c) One practicing physician who is participating in the Title XIX program
12 as a family practitioner recommended by the Louisiana State Medical Society.
13 (d) One practicing physician who is participating in the Title XIX program
14 as an internal medicine specialist recommended by the Louisiana State Medical
15 Society.
16 (e) One practicing physician who is participating in the Title XIX program
17 as a pediatrician recommended by the Louisiana State Medical Society.
18 (f) One practicing physician who is participating in the Title XIX program
19 as a surgeon recommended by the Louisiana State Medical Society.
20 (g) One practicing physician who is participating in the Title XIX program
21 as an obstetrics/gynecologist recommended by the Louisiana State Medical Society.
22 (h) Two practicing physicians who are participating in the Title XIX program
23 recommended by the Louisiana Medical Association.
24 (iii) Four physicians nominated by the Louisiana State Board of Medical
25 Examiners.
26 (i)(iv) One pharmacist representing nominated by the University of
27 Louisiana at Monroe School of Pharmacy.
28 (j)(v) One pharmacist representing nominated by the Xavier University of
29 Louisiana School of Pharmacy.
Page 2 of 4
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 27
SLS 18RS-141 ORIGINAL
1 (k)(vi) Two practicing pharmacists who are participating in the Title XIX
2 drug program nominated by the Louisiana State Board of Pharmacy. One
3 pharmacist shall be an independent pharmacist recommended by the Louisiana
4 Independent Pharmacies Association and one pharmacist shall be a pharmacist
5 representing a chain pharmacy recommended by the Louisiana Pharmacists
6 Association.
7 (l)(vii) The secretary of the Louisiana Department of Health, or his designee.
8 (m)(viii) The director of the Medicaid program in the Louisiana Department
9 of Health or his designee.
10 (n)(ix) The president of the Senate or the president's designee.
11 (o)(x) The speaker of the House of Representatives or the speaker's designee.
12 (p) One practicing physician who is participating in the Title XIX program
13 as a psychiatrist recommended by the Louisiana Psychiatric Medical Association.
14 (q)(xi) A consumer member who shall be a Medicaid recipient.
15 (r) One physician representing the Department of Neurology at Louisiana
16 State University Health Sciences Center.
17 (s) One physician who is a pediatric oncologist representing the Louisiana
18 State University Health Sciences Center.
19 (b) Any committee member who misses two consecutive meetings shall
20 be replaced. The department shall send notice to the nominating organization
21 upon the second recorded absence. The nominating organization shall have
22 thirty calendar days from issuance of the notice to submit replacement
23 nominations to the office of the governor. If replacement nominations are not
24 received within thirty days, the department shall nominate a replacement.
25 * * *
Page 3 of 4
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 27
SLS 18RS-141 ORIGINAL
The original instrument and the following digest, which constitutes no part
of the legislative instrument, were prepared by Christine Arbo Peck.
DIGEST
SB 27 Original 2018 Regular Session Mills
Present law provides for 21 members of the Medicaid Pharmaceutical and Therapeutics
Committee. Proposed law reduces the number of members to 15.
Present law provides that the committee shall be representative of the state's geographic and
demographic composition, including women and minorities. Proposed law requires that the
governor ensure race, gender, and geographic diversity in making his appointments.
Present law provides for committee membership nominations by trade associations.
Proposed law provides for committee membership nominations by state health profession
licensing boards.
Proposed law provides for replacement of committee members upon absence from two
consecutive meetings. Proposed law provides for the department to nominate a replacement
member if the nominating organization does not do so within 30 calendar days of notice that
its nominee has been removed from the committee.
Effective August 1, 2018.
(Amends R.S. 46:153.3(D)(1) and (2))
Page 4 of 4
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.